4
Changes in Ownership
Eledon Pharmaceuticals, Inc. Filed Acc 0001209191-21-052519
Chief Executive Officer bought 4,000 shares at $6.21 ($24,840)
From the SEC's structured data for this filing
Trades in this filing
Gros David-Alexandre C · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-17 | Purchase : show line 1 in the form | +4,000 | $6.21 | $24,840 | 7,000 | D |
| Open-market purchases · 4,000 sh · avg $6.21 · $24,840 | ||||||
Loading xslF345X03/doc4.xml…